Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

NOVO NORDISK A/S (NOVO.B)

246
Delayed Quote. Delayed BATS EUROPE - 04/24 05:29:59 pm
392.2500 DKK   +0.50%
04/23 For Western companies, Russia's recovery is worth waiting for
04/22 NOVO NORDISK A/ : A/S : - Share repurchase programme
04/22 NOVO NORDISK A/ : A/S : - Reduction of the share capital
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Copenhagen Stock Exchange
04/20/2015 04/21/2015 04/22/2015 04/23/2015 04/24/2015 Date
382.3 393.1 391.8 385.2 390.3 Last
3069141 3196405 3155843 2802716 2373465 Volume
+1.43% +2.83% -0.33% -1.68% +1.32% Change
Financials ( DKK)
Sales 2015 108 069 M
EBIT 2015 45 786 M
Net income 2015 31 618 M
Finance 2015 16 409 M
Yield 2015 1,47%
Sales 2016 117 492 M
EBIT 2016 50 545 M
Net income 2016 38 639 M
Finance 2016 19 288 M
Yield 2016 1,78%
PER 2015 32,07
PER 2016 25,74
EV / Sales 2015 7,30x
EV / Sales 2016 6,69x
Capitalization 805 019 M
More Financials
Company
Novo Nordisk AS engages in the research, development, manufacture, and marketing of pharmaceutical products.It operates through the Diabetes Care and Biopharmaceuticals segments.The Diabetes Care segment deals with the research, development, manufacture, and marketing of products within the areas... 
Sector
Pharmaceuticals
Calendar
04/30Earnings Release
More about the company
Surperformance© ratings of Novo Nordisk A/S
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVO NORDISK A/S
04/23 NOVO NORDISK A/S : Share repurchase programme
04/23 NOVO NORDISK A/S : Reduction of the share capital
04/23 For Western companies, Russia's recovery is worth waiting for
04/22 NOVO NORDISK A/S : Patent Issued for Determination of Position of Injection Need..
04/22 NOVO NORDISK A/S : Findings from Novo Nordisk Yields New Data on Rheumatoid Arth..
04/22 NOVO NORDISK A/S : Celebrates World Hemophilia Day and Shares New Support Progra..
04/22 NOVO NORDISK A/S : New Findings Reported from Novo Nordisk Describe Advances in ..
04/22 NOVO NORDISK A/S : A/S : - Share repurchase programme
More news
Sector news : Pharmaceuticals - NEC
12:05a ONO PHARMACEUTICAL : Bristol-Myers Squibb Receives Positive CHMP Opinion in the ..
04/26 ACTAVIS : ACT Gets Its Act Right, AKRX Shrivels, CUPID2 Misses Targets, GWPH On ..
04/26 PFIZER : Green chemistry pharmaceuticals launched in Pfizer's Groton labs going ..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
04/26 The Weekender
04/24 ARENA : Belviq Scripts Pop, Recover From Previous Dip
04/24 SEEKING ALPHA'S BIOTECH WEEKLY : Gilead Isn't Perfect, Biogen-Bass, Spring Fever..
04/23 Orexigen - Contrave Sales Outpace Competition, But Are Still Not Enough
04/23 What Novo Nordisk's Entry Into The Obesity Space Means To The Sector


Comments 
Advertisement
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF